Sanofi and CD&R are joining forces to fuel Opella’s ambitions as a French-headquartered, global consumer healthcare champion. Sanofi and CD&R have entered exclusive negotiations for the potential sale ...
Sanofi and CD&R enter exclusive talks to sell a 50% stake in Opella, Sanofi's consumer health unit, valued at $17.4 billion. Opella serves over 500M consumers globally with top brands like Allegra and ...
PARIS, Oct 11 (Reuters) - Sanofi (SASY.PA), opens new tab has entered into talks to sell a controlling 50% stake in its consumer health business Opella to U.S. private equity firm Clayton Dubilier & ...
France-based Sanofi S.A. (FR:SAN) is exploring the sale of its stake in its Consumer Health unit to an American private equity firm CD&R (Clayton, Dubilier & Rice). Following a report by Reuters, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results